Good Fit sample — Pharmaceutical Medical Information Assistant
Sample reports are illustrative examples designed to demonstrate Bodhvega capabilities. Actual assessment outputs vary based on problem context, industry, assumptions, and inputs.
Bodhvega Report
Your Assessment
- Architecture is retrieval-grounded with citation enforcement — not free generation.
- Reviewer gating is non-negotiable on every released response.
- PV signal routing is a first-class workflow concern, not an afterthought.
- All HCP-facing communication is subject to medical, legal, and regulatory review.
- Pharmacovigilance obligations apply to every enquiry channel.
- Approved content (labels, CDS, PV-cleared response documents) defines the boundary of allowable claims.
- Inspectors expect full traceability of who said what, on which evidence, with which version.
- Off-label content reaching an HCP creates a regulatory event.
- Missed PV signal at intake creates patient-safety and compliance risk.
- Stale corpus following a label update propagates incorrect responses.
- Medical-affairs sign-off on workflow design and on the approved corpus.
- Quarterly content-and-model audit with documented sampling.
- Change-control before any expansion beyond the Phase 1 product family.
Bodhvega is a decision-support tool. Here is a snapshot of how this assessment was put together.
- Confidence
- High
- Industry context
- Pharmaceuticals
- Assumptions used
- 6
- Information gaps
- 4
- Opportunity sizing
- Appropriate Scope
Use case is well-bounded, content corpus is identifiable, and reviewer-gated workflows are standard in this industry.
A governed knowledge-retrieval assistant can materially accelerate the medical information desk while preserving regulatory control.
Strong — proceed
12–16 weeks for a controlled launch on a single product family
78 / 100
Why Now
- Approved content is already digital and reasonably well-structured, making RAG feasible.
- Regulatory expectations on traceability align well with RAG citation enforcement.
- Enquiry volume is outpacing the team's ability to scale linearly with headcount.
Situation
A mid-size pharmaceutical company's Medical Information team handles ~3,500 healthcare-professional (HCP) enquiries per month across 14 marketed products. Responses must be drawn only from approved labels, core data sheets, and PV-cleared response documents. Median response time is 36 hours; the team is struggling to keep up with launches and regulatory cycles.
Recommendation
Deploy a governed retrieval-augmented (RAG) assistant that drafts responses to inbound HCP enquiries strictly from an approved content corpus, with mandatory medical-affairs review prior to release, full citation traceability, and PV signal-routing on suspected adverse events.
Response throughput and turnaround
Cutting median response time from 36 hours to under 6 hours, with capacity to absorb 30–40% more enquiry volume without additional headcount.
Off-label or fabricated content reaching HCPs
Any response that references information outside the approved corpus would create a regulatory event. Mitigated by retrieval-only generation, mandatory medical-affairs review, and citation enforcement.
AI Fit Score: 78/100
- Task benefits from LLM language fluency over a curated, retrievable corpus.
- Human-irreplaceable judgement is preserved through reviewer gating, capping autonomy at 2.
- Score capped at 78 because PV obligations and label-update freshness add residual risk.
- ROI is concrete: throughput, capacity, and reviewer productivity are quantified.
- Risk envelope is bounded by mandatory reviewer release on every response.
- Approved content is digital, versioned, and accessible via API.
- Medical reviewers have capacity to review drafts at projected enquiry volumes.
- PV intake exposes an API or queue for routed suspected adverse events.
- Provider BAA and EU data residency are achievable with the selected platform.
- Inspectors will accept citation chains stored in the workflow's audit log as evidence.
- Phase 1 scope is limited to a single product family.
Phase 1 is bounded to a single product family with reviewer gating, with measurable ROI in 12–16 weeks.
- Sample of 100 representative enquiries to test retrieval and PV detection performance.
- Current PV intake API maturity and latency.
- Frequency and channel of label updates per product.
- Reviewer calibration baseline for accept/edit/reject behaviour.
This assessment is based on the information provided and generated using Bodhvega's structured evaluation framework. Results may vary depending on industry-specific requirements, regulatory constraints, organizational maturity, data quality and availability, existing technology landscape, and business operating model. This assessment should be used as decision-support guidance and not as a substitute for detailed business, architectural, legal, or regulatory review.